﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Generated by www.ashp.org on Sun, 08 Nov 2009 02:00:29--><rss version="2.0"><channel><title>ASHP Health-System Pharmacy Press Releases and Announcements</title><link>http://www.ashp.org/Import/NEWS/PressReleases.aspx</link><description>ASHP Health-System Pharmacy Press Releases and Announcements</description><language>en-us</language><copyright>Copyright2009 ASHP</copyright><docs>http://blogs.law.harvard.edu/tech/rss/</docs><lastBuildDate>Sun, 08 Nov 2009 02:00:29</lastBuildDate><image><url>http://www.ashp.org/images/ashprss.gif</url><title>ASHP</title><link>http://www.ashp.org/</link><width>57</width><height>34</height></image><item><title><![CDATA[ASHP Survey Reveals Hospital Workers Concerned About Flu Vaccines]]></title><link>http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=543</link><description><![CDATA[Hospital workers are asking the same questions about the safety and necessity of flu vaccines as the general public, according to a survey conducted by the American Society of Health-System Pharmacists (ASHP).&#160;
&#160;The survey of pharmacy directors at 341 hospitals across the country raise troubling concerns about whether health care workers will choose to get vaccinated against H1N1 and seasonal flu.&#160;ASHP advocates that all health care workers should receive an annual influenza vaccination. &#8220;It is extremely important that health care workers, as well as all hospital staff, get vaccinated for both H1N1 and seasonal flu,&#8221; said ASHP President Lynnae Mahaney, M.B.A., FASHP.&#160; &#8220;Health care workers come into contact with so many people, it is vital that they are vaccinated to minimize the risk to patients.&#8221;&#160;The survey finds that both patients and hospital staff are asking pharmacists the following questions:Is the H1N1 vaccine safe?
    Do I need to get the H1N1 vaccine?
    Will there be enough H1N1 vaccine to around?&#160; 
&#8220;The H1N1 vaccine is prepared using the same methods as the seasonal flu vaccine,&#8221; said Mahaney. &#8220;Clinical testing shows this vaccine is safe and should definitely be used by people who are at most risk.&#8221;&#160; The Centers for Disease Control and Prevention recommends that the following groups of people should be vaccinated for H1N1 as soon as possible:Pregnant women,
    People who live with or care for children younger than 6 months of age,
    Health care and emergency medical services personnel,
    Persons between 6 months and 24 years old, and
    Persons between 25 and 64 years old who are at higher risk because of chronic health disorders or compromised immune systems. &#160;Once the above groups have been vaccinated, the CDC recommends vaccinating everyone between 25 and 64 years of age.&#160;The survey finds that hospitals are preparing for possible staffing shortages caused by the pandemic by identifying minimum staffing levels, differentiating between critical and non-essential services, and planning to reassign job responsibilities.&#160; In addition, the survey reveals that nearly all pharmacy departments surveyed are collaborating with local and state health departments to coordinate H1N1 response efforts in the community. &#160;While pharmacists are authorized to administer vaccinations to adults, the survey also finds that most hospitals are not planning to utilize pharmacists for this service.&#160; &#8220;ASHP encourages hospitals and health systems to consider using pharmacists to administer vaccines in order to help increase vaccination rates,&#8221; said Mahaney.&#160; &#8220;Especially in light of reports of cuts in public health budgets at the state and local level that may leave communities understaffed for these important efforts.&#8221;&#160;The survey also shows gaps in seasonal flu vaccination rates for health care workers, with only 37 percent of respondents reporting vaccination rates over 70 percent at their hospitals.&#160; &#8220;That&#8217;s too low,&#8221; said Mahaney, who cautioned this finding suggests there may be a similar gap in H1N1 vaccinations for health care workers.&#160;ASHP has online resources for health care workers about seasonal and H1N1 flu.&#160; At www.YouCanStopTheFlu.com, pharmacists can find numerous resources to help their efforts to improve seasonal influenza immunization rates among health care workers.&#160; Pharmacists can find specific resources and information about H1N1 at www.ashp.org/H1N1.&#160;ASHP&#8217;s Influenza Planning Survey results can be found at www.ashp.org/flusurvey.&#160;About ASHPFor more than 60 years, ASHP has helped pharmacists who practice in hospitals and health systems improve medication use and enhance patient safety. The Society's 35,000 members include pharmacists and pharmacy technicians who practice in inpatient, outpatient, home-care, and long-term-care settings, as well as pharmacy students. For more information about the wide array of ASHP activities and the many ways in which pharmacists help people make the best use of medicines, visit ASHP's Web site, www.ashp.org, or its consumer Web site, www.SafeMedication.com.&#160;]]></description><category>Press Release</category><guid isPermaLink="false">http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=543</guid><pubDate>Tue, 13 Oct 2009</pubDate></item><item><title><![CDATA[New Book Helps Pharmacists Prepare for Role in H1N1 and Other Public Health Crises]]></title><link>http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=542</link><description><![CDATA[With the flu season and the H1N1 virus looming, pharmacists are increasingly being called on to take a more active role in public health, from immunizations to disaster planning and management. ASHP&#8217;s new book, Pharmacy in Public Health: Basics and Beyond, provides pharmacists and other health care practitioners with critical information they&#8217;ll need to play a much-needed role in public health, for flu season, emergency preparedness, and chronic disease prevention and management.]]></description><category>Press Release</category><guid isPermaLink="false">http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=542</guid><pubDate>Mon, 05 Oct 2009</pubDate></item><item><title><![CDATA[New Online Tool Focuses On Improving Influenza Immunization Rates For Health Professionals]]></title><link>http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=541</link><description><![CDATA[Recognizing that influenza infection in health care workers can lead to outbreaks with serious consequences for patients, the American Society of Health-System Pharmacists (ASHP) has launched an initiative for pharmacists to improve influenza immunization rates among healthcare workers.&#160;Health care workers can acquire influenza and unwittingly transmit the virus to patients, other health care workers, and members of their household and the community a day or two before symptoms appear.]]></description><category>ASHP Action Line</category><guid isPermaLink="false">http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=541</guid><pubDate>Tue, 15 Sep 2009</pubDate></item><item><title><![CDATA[Leaders in Hospital Care Form New Collaborative to Address Pressing Issues for Patient Care]]></title><link>http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=540</link><description><![CDATA[In]]></description><category>ASHP Action Line</category><guid isPermaLink="false">http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=540</guid><pubDate>Wed, 09 Sep 2009</pubDate></item><item><title><![CDATA[ASHP's Online Quality Improvement Resource Center Offers New Tools]]></title><link>http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=539</link><description><![CDATA[The]]></description><category>ASHP Action Line</category><guid isPermaLink="false">http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=539</guid><pubDate>Thu, 03 Sep 2009</pubDate></item><item><title><![CDATA[ASHP Statement on the Death of Senator Edward Kennedy]]></title><link>http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=538</link><description><![CDATA[Senator Edward M. Kennedy&#8217;s passing is a true loss to pharmacy. Senator Kennedy&#8217;s willingness to embrace the value of pharmacists&#8217; services played a significant role in achieving a place for pharmacists in the current health- care reform legislation. Kennedy was also instrumental in the 1960&#8217;s and 1970&#8217;s in creating legislation that advanced pharmacy education and clinical pharmacy services. Through the years, he and his staff have always been open to hearing from ASHP on issues related to safe medication use and the role of pharmacists on the patient care team. We have lost a true friend and champion on Capitol Hill.Henri R. Manasse, Jr., Ph.D., Sc.D
Executive Vice President—Chief Executive Officer
American Society of Health-System Pharmacists]]></description><category>ASHP Action Line</category><guid isPermaLink="false">http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=538</guid><pubDate>Wed, 26 Aug 2009</pubDate></item><item><title><![CDATA[Online Resource Highlights Pharmacists’ Contributions to Improve Health Care Quality]]></title><link>http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=535</link><description><![CDATA[A new Web resource from the American Society of Health-System Pharmacists (ASHP) sheds light on the critical role that pharmacists are playing in efforts to transform the health care system and improve the quality of care for patients in hospitals and health systems. 
    &#160;
    ASHP&#8217;s Web resource, www.ashp.org/qii/npp, is one of the outcomes of the Society&#8217;s involvement in the National Priorities Partnership (NPP), an initiative convened by the National Quality Forum. The NPP has identified six national priorities aimed at eliminating waste, harm, and disparities in the health care system. The six national priorities are overuse, safety, care coordination, patient and family engagement, end-of-life care, and population health.
  
  
    The ASHP site makes the case for the critical role of pharmacists in each of the six priorities and points to innovative examples of pharmacists&#8217; efforts to achieve improved outcomes for patients that result in reduced costs. The site also provides hospital and health-system pharmacy departments with resources to help implement ASHP best practices by offering links to relevant evidence in the scientific literature as well as related ASHP policies and resources.]]></description><category>ASHP Action Line</category><guid isPermaLink="false">http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=535</guid><pubDate>Mon, 03 Aug 2009</pubDate></item><item><title><![CDATA[ASHP House of Delegates Moves Forward on Pressing Practice Issues]]></title><link>http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=536</link><description><![CDATA[The House of Delegates of the American Society of Health-System Pharmacists (ASHP) considered a number of vital professional issues during its 61st annual session, including the development of standards for the disposal of pharmaceutical waste, involving pharmacists in key decision-making roles in health care information systems, encouraging pharmacists to report potential medication errors, and advocating the expansion of collaborative drug therapy management (CDTM) practices.&#160; The session was held June 14 and 16 in Rosemont, Ill. in conjunction with Society&#8217;s Summer Meeting.&#160; 
The House of Delegates, ASHP&#8217;s chief policy-making body, consists of 163 voting state delegates (a minimum of two from each state, the District of Columbia, and Puerto Rico), members of the Board of Directors, past presidents of ASHP, chairs of the Society&#8217;s sections and forums, and five delegates representing the federal services.&#160; POLICY ACTIONS
The House approved the following professional policies.
Workload Monitoring and Reporting: To strongly discourage the use of pharmacy workload and productivity measurement systems (&#8220;pharmacy benchmarking systems&#8221;) that are based solely upon dispensing functions (e.g., doses dispensed or billed) or a variant of patient days, because such measures do not accurately assess pharmacy workload, staffing effectiveness, clinical practice contributions to patient care, or impacts on costs of care, and therefore these measurement systems are not valid and should not be used; further, to advocate the development and implementation of pharmacy benchmarking systems that accurately assess the impact of pharmacy services on patient outcomes and total costs of care; further, to define pharmacy workload as all activities related to providing pharmacy patient care services; further, to continue communications with health-system administrators, consulting firms, and professional associations regarding the value of pharmacists&#8217; services and the importance of using valid, comprehensive, and evidence-based measures of pharmacy workload and productivity; further, to encourage practitioners and vendors to develop and use a standard protocol for collecting and reporting pharmacy workload data and patient outcomes; further, to advocate to health-system administrators, consulting firms, and vendors of performance-measurement services firms the development and implementation of pharmacy benchmarking systems that accurately assess the impact of pharmacy services on patient outcomes and total costs of care. (Replaces ASHP policy 0406.)Pharmacist&#8217;s Role in Providing Care for an Aging Population: To encourage expansion of geriatric health care services; further, to foster expanded roles for pharmacists in caring for geriatric patients; further, to support successful innovative models of team-based, interdisciplinary geriatric care; further, to increase training of pharmacists in caring for geriatric patients within college of pharmacy curricula, in ASHP-accredited postgraduate-year-one residencies, and through the expansion of the number of ASHP-accredited postgraduate-year-two geriatric pharmacy residency programs.Pharmaceutical Waste: To collaborate with regulatory bodies and appropriate organizations to develop standards for the disposal of pharmaceutical hazardous waste as defined in the Resource Conservation and Recovery Act (RCRA), for the purpose of simplifying the disposal of these substances by health systems; further, to encourage pharmaceutical manufacturers and the Environmental Protection Agency (EPA) to provide guidance and assistance to hospitals and health systems in proper pharmaceutical waste disposal and destruction efforts; further, to advocate that EPA update the list of hazardous substances under RCRA and establish a process for maintaining a current list; further, to urge federal, state, and local governments to harmonize regulations regarding disposal of hazardous pharmaceutical waste; further, to advocate that the Food and Drug Administration standardize labeling of drug products with information relating to appropriate disposal; further, to promote awareness within hospitals and health systems of pharmaceutical waste regulations; further, to encourage research on the environmental and public health impacts of drug products and metabolites excreted in human waste; further, to encourage pharmaceutical manufacturers to streamline packaging of drug products to reduce waste materials. (Replaces ASHP policy 0231.)Automatic Stop Orders: To advocate that the Centers for Medicare &amp; Medicaid Services (1) revise the requirement in the Hospital Conditions of Participation that all medication orders automatically stop after an arbitrarily assigned period to include other options to protect patients from indefinite, open-ended medication orders, and (2) revise the remainder of the medication management regulations and interpretive guidelines to be consistent with this practice.Credentialing and Privileging by Regulators, Payers, and Providers for Collaborative Drug Therapy Management: To advocate expansion of collaborative drug therapy management (CDTM) practices in which the prescriber and the licensed pharmacist agree upon the conditions under which the pharmacist initiates, monitors, and adjusts a patient&#8217;s drug therapy; further, to acknowledge that as a step toward the goal of universal recognition of and payment for pharmacist CDTM services, public or private third-party payers may require licensed pharmacists to demonstrate their competence to provide CDTM, before the payers authorize them to engage in or be paid for such clinical services; further, to support (1) the development (as a professional initiative by pharmacist associations rather than as a government activity) of national standards for determining a pharmacist&#8217;s competence to provide CDTM and (2) the appropriate use of these standards by clinical privileging systems, government authorities, and public or third-party payers; further, to support the use of clinical privileging by hospitals and health systems to assess a licensed pharmacist&#8217;s competence to engage in CDTM within the hospital or health system; further, to advocate that state boards of pharmacy apply the principles of continuous quality improvement in assessing the quality, safety, and outcomes of CDTM. (Note:&#160; &#8220;Privileging&#8221; is the process by which an oversight body of a health care organization or other appropriate provider body, having reviewed an individual health care provider&#8217;s credentials and performance and found them satisfactory, authorizes that individual to perform a specific scope of patient care services within that setting. Replaces ASHP policy 0318.)&#160;Approval of Follow-on Biological Medications: To encourage the development of safe and effective follow-on biological medications in order to make such medications more affordable and accessible; further, to encourage research on the safety, effectiveness, and interchangeability of follow-on biological medications; further, to support legislation and regulation to allow Food and Drug Administration approval of follow-on biological medications; further, to require postmarketing surveillance for all follow-on biological medications to ensure their continued safety, effectiveness, purity, quality, identity, and strength; further, to advocate for adequate reimbursement for biological medications that are deemed interchangeable; further, to promote education of pharmacists about follow-on biological medications and their appropriate use within hospitals and health systems; further, to encourage pharmacist evaluation and the application of the formulary system before follow-on biological medications are used in hospitals and health systems.&#160; (Note:&#160; Follow-on biological medications are also referred to as biosimilars, follow-on protein products, biogenerics, comparable biologicals, and generic biopharmaceuticals. Replaces ASHP policy 0519.)&#160;Pharmaceutical Product and Supply Chain Integrity: To encourage the Food and Drug Administration (FDA) and relevant state authorities to take the steps necessary to ensure that (1) all drug products entering the supply chain are thoroughly inspected and tested to establish that they have not been adulterated or misbranded and (2) patients will not receive improperly labeled and packaged, deteriorated, outdated, counterfeit, adulterated, or unapproved drug products; further, to encourage FDA and relevant state authorities to develop and implement regulations to (1) restrict or prohibit licensed drug distributors (drug wholesalers, repackagers, and manufacturers) from purchasing legend drugs from unlicensed entities and (2) ensure accurate documentation at any point in the distribution chain of the original source of drug products and chain of custody from the manufacturer to the pharmacy; further, to advocate the establishment of meaningful penalties for companies that violate current good manufacturing practices (cGMPs) intended to ensure the quality, identity, strength, and purity of their marketed drug product(s) and raw materials; further, to urge Congress and state legislatures to provide adequate funding, or authority to impose user fees, to accomplish these objectives. (Replaces ASHP policy 0722.)Pharmacist Role in the Health Care (Medical) Home: To advocate to health policymakers, payers, and other stakeholders for the inclusion of pharmacists as a care provider within the health care (medical) home model; further, to ensure that there are appropriate reimbursement mechanisms for the care that pharmacists provide (including care coordination services) within the health care home model; further, to advocate to the Centers for Medicare &amp; Medicaid Services that pharmacists be included in demonstration projects for the health care home model; further, to encourage comparative effectiveness research and measurement of key outcomes (e.g., clinical, economic, quality, access) for pharmacist services in the health care home model.Regulation of Interstate Pharmacy Practice: To advocate that state governments, including legislatures and boards of pharmacy, adopt laws and regulations that harmonize the practice of pharmacy across state lines in order to provide a consistent, transparent, safe, and accountable framework for pharmacy practice.Reporting Medication Errors: To encourage pharmacists to exert leadership in establishing a just culture in their workplaces and a nonpunitive systems approach to addressing medication errors while supporting a nonthreatening reporting environment to encourage pharmacy staff and others to report actual and potential medication errors in a timely manner; further, to provide leadership in supporting a single, comprehensive medication error reporting program that (1) fosters a confidential, nonthreatening, and nonpunitive environment for the submission of medication error reports; (2) receives and analyzes these confidential reports to identify system-based causes of medication errors or potential errors; and (3) recommends and disseminates error prevention strategies; further, to provide leadership in encouraging the participation of all stakeholders in the reporting of medication errors to this program. (Note:&#160; A just culture recognizes that individual practitioners should not be held accountable for system failings over which they have no control, and that many individual or &#8220;active&#8221; errors represent predictable interactions between human operators and the systems in which they work. However, a just culture does not tolerate conscious disregard of clear risks to patients or gross misconduct. Replaces ASHP policy 9918.)&#160;Stable Funding for Office of Pharmacy Affairs: To advocate for adequate funding for the Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs to support its public health mission; further, to support initiatives of the Office of Pharmacy Affairs, including the 340B Drug Pricing Program and innovative pharmacy service models in HRSA-funded programs.Safe and Effective Use of Heparin in Neonatal Patients: To support the development and use of nationally standardized concentrations of heparin when used for maintenance and flush of peripheral and central venous lines in neonatal patients; further, to advocate that hospitals and health systems use manufacturer-prepackaged heparin flush products to improve the safe use of heparin in neonatal patients.Pharmacy Student Experiences in Medically Underserved Areas: To encourage colleges of pharmacy to require student learning experiences in traditionally medically underserved areas and with diverse patient populations.Education about Patient Safety in the Medication-Use Process: To encourage colleges of pharmacy to include instruction on patient safety throughout the medication-use process in the didactic curriculum and during experiential education.Pharmacy Expertise in the Preparation and Handling of Injectable Medications: To encourage colleges of pharmacy to include sterile compounding and aseptic technique instruction in the didactic curriculum and during experiential education; further, to support the development of postgraduate, curriculum-based sterile compounding training programs to foster an increase in the number of pharmacists with sterile compounding expertise.Continuing Professional Development: To endorse and promote the concept of continuing professional development (CPD), which involves personal self-appraisal, educational plan development, plan implementation, documentation, and evaluation; further, to continue the development of a variety of mechanisms and tools that pharmacists can use to assess their CPD needs; further, to encourage individual pharmacists to embrace CPD as a means of maintaining their own professional competence; further, to encourage pharmacy managers to promote CPD as the model for ensuring the competence of their staff; further, to collaborate with other pharmacy organizations, state boards of pharmacy, accrediting bodies, and regulatory bodies in the development of effective methods for implementing CPD; further, to strongly support objective assessment of the impact of CPD on pharmacist competence; further, to endorse the efforts of colleges of pharmacy and ASHP-accredited pharmacy residency programs to teach the principles, concepts, and skills of CPD. (Replaces ASHP policy 0408.)
Pharmacy Residency Training:To continue efforts to increase the number of ASHP-accredited pharmacy residency training programs and positions available. (Replaces ASHP policy 9911.)Pharmacist Leadership of the Pharmacy Department: To affirm the importance of an organizational structure in hospitals and health systems that places administrative, clinical, and operational responsibility for the pharmacy department under a pharmacist leader; further, to affirm the role of the pharmacist leader in oversight and supervision of all pharmacy personnel; further, to recognize the supporting role of nonpharmacists in leadership and management roles within pharmacy departments. (Replaces ASHP policy 0606.)Intimidating or Disruptive Behaviors: To affirm the professional responsibility of the pharmacist to ensure patient safety by communicating with other health care personnel to clarify and improve medication management; further, to advocate that hospitals and health systems adopt zero-tolerance policies for intimidating or disruptive behaviors; further, to encourage hospitals and health systems to develop and implement education and training programs for all health care personnel to encourage effective communication and discourage intimidating or disruptive behaviors; further, to encourage colleges of pharmacy and residency training programs to incorporate training in communications and managing intimidating or disruptive behaviors; further, to collaborate with other organizations to advocate codes of conduct that minimize intimidating or disruptive behavior in hospitals and health systems.
Standardized Clinical Drug Nomenclature: To encourage federal agencies, the pharmaceutical industry, pharmacy and medical software providers, and purveyors of clinical data repositories and drug databases to explore the potential benefits of supplementing or modifying the National Drug Code with a coding system that can be used effectively to support patient care, research, and financial management; further, to encourage that such a coding system encompass prescription drug products, nonprescription medications, and dietary supplements and include both active and inactive ingredients. (Replaces ASHP policy 0801.)Pharmacist&#8217;s Role in Health Care Information Systems: To strongly advocate key decision-making roles for pharmacists in the planning, selection, design, implementation, and maintenance of pharmacy information systems, electronic health records, computerized provider order entry systems, and e-prescribing systems to facilitate clinical decision support, data analysis, and education of users for the purpose of ensuring the safe and effective use of medications; further, to advocate for incentives to hospitals and health systems for the adoption of patient care technologies. (Replaces ASHP policy 0203.)&#160;ASHP STATEMENTS
Delegates approved the following ASHP Statements, which are documents that elaborate on best practices in health-system pharmacy.&#160; These documents may be obtained from the ASHP Web site at&#160;http://www.ashp.org/Import/PRACTICEANDPOLICY/PolicyPositionsGuidelinesBestPractices.aspxor by contacting the ASHP Public Relations Division.ASHP Statement on the Pharmacist&#8217;s Role in Antimicrobial Stewardship and Infection Prevention and Control
    ASHP Statement on the Health-System Pharmacist&#8217;s Role in National Health Care Quality InitiativesAbout ASHPFor more than 60 years, ASHP has helped pharmacists who practice in hospitals and health systems improve medication use and enhance patient safety. The Society's 35,000 members include pharmacists and pharmacy technicians who practice in inpatient, outpatient, home-care, and long-term-care settings, as well as pharmacy students. For more information about the wide array of ASHP activities and the many ways in which pharmacists help people make the best use of medicines, visit ASHP's Web site, www.ashp.org, or its consumer Web site, www.SafeMedication.com.]]></description><category>ASHP Action Line</category><guid isPermaLink="false">http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=536</guid><pubDate>Mon, 27 Jul 2009</pubDate></item><item><title><![CDATA[Survey Reveals Public's Concerns About Prescription Medication Overdose Risks Following Death of Michael Jackson]]></title><link>http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=534</link><description><![CDATA[Survey results released by The American Society of Health-System Pharmacists (ASHP) revealed the effects of publicity around Michael Jackson&#8217;s alleged prescription drug misuse.&#160; More than 200 pharmacists who work in home, ambulatory, and chronic care practices responded to the survey conducted on July 1, 2009.]]></description><category>Press Release</category><guid isPermaLink="false">http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=534</guid><pubDate>Tue, 07 Jul 2009</pubDate></item><item><title><![CDATA[Mahaney Installed as ASHP President]]></title><link>http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=533</link><description><![CDATA[Lynnae M. Mahaney, M.B.A., FASHP, was installed this week as president of the American Society of Health-System Pharmacists (ASHP) during the 61st session of the Society&#8217;s House of Delegates in Rosemont, Ill.]]></description><category>ASHP Action Line</category><guid isPermaLink="false">http://www.ashp.org/import/news/PressReleases/pressrelease.aspx?id=533</guid><pubDate>Wed, 17 Jun 2009</pubDate></item></channel></rss>